Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.

Futrakul N, Futrakul P.

World J Nephrol. 2013 Nov 6;2(4):125-8. doi: 10.5527/wjn.v2.i4.125. Review.

2.

Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy.

Futrakul N, Kulaputana O, Futrakul P, Chavanakul A, Deekajorndech T.

Ren Fail. 2011;33(3):312-5. doi: 10.3109/0886022X.2011.560405.

PMID:
21401356
3.

Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes.

Futrakul N, Futrakul P.

Int J Vasc Med. 2011;2011:971524. doi: 10.1155/2011/971524. Epub 2011 May 24.

4.

Altered vascular homeostasis in type 2 diabetic nephropathy.

Futrakul N, Butthep P, Futrakul P.

Ren Fail. 2009;31(3):207-10. doi: 10.1080/08860220802669859.

PMID:
19288326
5.

Biomarker for early renal microvascular and diabetic kidney diseases.

Futrakul N, Futrakul P.

Ren Fail. 2017 Nov;39(1):505-511. doi: 10.1080/0886022X.2017.1323647.

PMID:
28494191
6.

Urgent call for reconsideration of chronic kidney disease.

Futrakul N, Futrakul P.

World J Nephrol. 2012 Dec 6;1(6):155-9. doi: 10.5527/wjn.v1.i6.155.

7.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

8.

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.

Mogensen CE.

J Intern Med. 2003 Jul;254(1):45-66. Review.

9.

Early stage of vascular disease and diabetic kidney disease: an under-recognized entity.

Futrakul N, Chanakul A, Futrakul P, Deekajorndech T.

Ren Fail. 2015;37(8):1243-6. doi: 10.3109/0886022X.2015.1073054. Epub 2015 Sep 11. Review.

PMID:
26365595
10.

Improvement of renal function in type 2 diabetic nephropathy.

Futrakul N, Butthep P, Futrakul P, Sitprija V.

Ren Fail. 2007;29(2):155-8.

PMID:
17365929
11.

Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.

McKenna K, Thompson C.

Scott Med J. 1997 Aug;42(4):99-104. Review.

PMID:
9507584
12.

The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.

Chiarelli F, Verrotti A, Mohn A, Morgese G.

Ann Med. 1997 Oct;29(5):439-45. Review.

PMID:
9453292
13.

Losartan in diabetic nephropathy.

Perico N, Ruggenenti P, Remuzzi G.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. Review.

PMID:
15225108
14.
15.

Twelve shifting paradigms in diabetic renal disease and hypertension.

Mogensen CE.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S2-9. doi: 10.1016/j.diabres.2008.09.029. Epub 2008 Oct 23.

PMID:
18947897
16.

WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.

Lovell HG.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD002183. Review.

PMID:
17636698
17.

Renal microvascular disease predicts renal function in diabetes.

Futrakul N, Futrakul P.

Ren Fail. 2012;34(1):126-9. doi: 10.3109/0886022X.2011.623490. Epub 2011 Oct 20.

PMID:
22010784
18.
19.
20.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209

Supplemental Content

Support Center